Henislie Corp., a newly formed organization based in Beverly Hills, CA, is working to raise approximately $50m to to fund the commercialization of promising technologies.
The organization will focus on making seed investments in companies focusing on life science, information technology, telecommunications and clean energy production with short-term proof-of-concept financing, as well as investing in startups.
Henislie is a joint venture created by Imprimatur Capital and BioAccel to solve the funding and technical expertise gap faced by emerging technology companies in today’s demanding economic climate in the USA.
It is concentrating its initial efforts in Arizona, Southern California and Texas, and will expand countrywide in the future.
FinSMEs
07/11/2010